PSA prostate cancer screening found more beneficial than previous estimates, especially for blacks Dr. Kamal Kant Kohli13 Jun 2022 2:30 PM GMTNew research led by investigators from Weill Cornell Medicine, Fred Hutchinson Cancer Center, University Hospitals Cleveland and Case Western Reserve...
Intake of dairy milk may pose a greater risk for prostate cancer Dr. Nandita Mohan13 Jun 2022 4:30 AM GMTMen with higher intakes of dairy foods, especially milk, face a significantly higher risk of prostate cancer compared to men with lower intakes. This...
Metformin and statins improve overall survival in men with castration-resistant metastatic prostate cancer: Study Medha Baranwal10 Jun 2022 2:30 PM GMTCanada: The use of metformin and statins results in prolonged overall survival and an improved response rate of prostate-specific antigen (PSA),...
Intake of 5-ARIs for BPH not associated with increased mortality in prostate cancer Dr. Kamal Kant Kohli7 Jun 2022 2:00 PM GMTResearchers have found in a new study that Intake of 5-ARIs for BPH is not associated with increased mortality in prostate cancer. The study has been...
New combined therapy helps extend lives of men with prostate cancer Dr. Kamal Kant Kohli29 May 2022 2:00 PM GMTPractice-changing research from Cedars-Sinai Cancer shows that a combination of androgen deprivation therapy-a commonly used hormone injection-plus...
Obese Smokers at higher risk of dying from prostate cancer: Study Medical Dialogues Editorial Team27 May 2022 2:30 PM GMTSweden: The reduced prostate cancer (PCa) risk for smokers throughout the PSA era, especially for low-risk PCa, is most likely due to smokers' low...
Addition of androgen deprivation therapy to PBRT halts progression of prostate cancer: Lancet Medical Dialogues Editorial Team24 May 2022 4:00 AM GMTA new study published in The Lancet shows the advantage of combining short-term androgen deprivation treatment (ADT) with prostate bed radiation...
Glenmark Pharma bags USFDA nod for prostate cancer drug Abiraterone Acetate Ruchika Sharma20 May 2022 6:45 AM GMTProstate cancer is a disease in which malignant (cancer) cells form in the tissues of the prostate.
Myovant Sciences, Accord Healthcare ink pact for prostate cancer treatment Relugolix Ruchika Sharma10 May 2022 4:45 AM GMTORGOVYX (relugolix, 120 mg) is indicated in Europe for the treatment of adult patients with advanced hormone-sensitive prostate cancer.
Researchers look to licorice for promising treatment of prostate cancer Dr. Kamal Kant Kohli7 May 2022 3:30 AM GMTLicorice is more than a candy people either love or hate-it may play a role in preventing or treating certain types of cancer, according to...
Bayer gets USFDA priority review for darolutamide plus docetaxel to treat metastatic hormone-sensitive prostate cancer Ruchika Sharma4 May 2022 6:30 AM GMTDarolutamide is developed jointly by Bayer and Orion Corporation, a globally operating Finnish pharmaceutical company.
Less prostate cancer screening reduces overdiagnosis but may miss aggressive cases Dr. Kamal Kant Kohli28 April 2022 3:30 AM GMTOver the past 15 years, public health authorities have downgraded recommendations for the prostate-specific antigen (PSA) test as a screening tool to...
